An Evaluation of Diabetes-Related Measures of Control After 6 Months of Clinical Pharmacy Specialist Intervention (Q48849892)

16 February 2018

title

An evaluation of diabetes-related measures of control after 6 months of clinical pharmacy specialist intervention (English)

1 reference

16 February 2018

An Evaluation of Diabetes-Related Measures of Control After 6 Months of Clinical Pharmacy Specialist Intervention (English)

1 reference

https://api.crossref.org/works/10.1177/0897190010392235

4 December 2024

0 references

Wendy Johnson

1 reference

16 February 2018

Regina Cassidy

1 reference

16 February 2018

Dharapuram Venugopal

1 reference

16 February 2018

Rebecca J. Cripps

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21676857

4 December 2024

Eric S. Gourley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21676857

4 December 2024

Timothy C. Morgan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21676857

4 December 2024

M. Shawn McFarland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21676857

4 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21676857

4 December 2024

publication date

18 March 2011

1 reference

16 February 2018

full work available at URL

https://journals.sagepub.com/doi/pdf/10.1177/0897190010392235

1 reference

https://api.crossref.org/works/10.1177/0897190010392235

https://journals.sagepub.com/doi/full-xml/10.1177/0897190010392235

4 December 2024

1 reference

https://api.crossref.org/works/10.1177/0897190010392235

Journal of Pharmacy Practice

4 December 2024

published in

1 reference

16 February 2018

volume

1 reference

16 February 2018

issue

1 reference

16 February 2018

page(s)

332-338

1 reference

16 February 2018

Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Economic costs of diabetes in the US in 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Effect of improved glycemic control on health care costs and utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Standards of medical care in diabetes--2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Diabetes process and outcome measures in the Department of Veterans Affairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

The effectiveness of disease and case management for people with diabetes. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Management of patients with type 2 diabetes by pharmacists in primary care clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

A multifaceted intervention in support of diabetes treatment guidelines: a cont trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Attitudes and behaviors of primary care physicians regarding tight control of blood glucose in IDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Population-based assessment of the level of care among adults with diabetes in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Effectiveness of pharmacist-administered diabetes mellitus education and management services

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Effects of intensive blood-pressure control in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Poor applicability of the Friedewald formula in the assessment of serum LDL cholesterol for clinical purposes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190010392235

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190010392235

Interventions Among Primary-Care Practitioners to Improve Care for Preventable Complications of Diabetes

4 December 2024

1 reference

https://api.crossref.org/works/10.1177/0897190010392235

Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention

4 December 2024

1 reference

https://api.crossref.org/works/10.1177/0897190010392235

Metabolic control and adherence to american diabetes association practice guidelines in a pharmacist-managed diabetes clinic

4 December 2024

1 reference

https://api.crossref.org/works/10.1177/0897190010392235

Reported practice behaviors for medical care of patients with diabetes mellitus by primary-care physicians in Pennsylvania

4 December 2024

1 reference

https://api.crossref.org/works/10.1177/0897190010392235

4 December 2024

Identifiers

1 reference

16 February 2018

1 reference

16 February 2018